A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants
Condition(s):HealthyLast Updated:January 6, 2017Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:January 6, 2017Completed
Condition(s):Meningococcal Immunisation; Healthy VolunteersLast Updated:October 3, 2023Completed
Condition(s):ImmunodeficiencyLast Updated:April 11, 2023Completed
Condition(s):Diphtheria; Tetanus; PertussisLast Updated:October 31, 2022Completed
Condition(s):Heterologous Effects of VaccinesLast Updated:July 27, 2017Unknown status
Condition(s):Vaccination; Infection; Maternal-Fetal Relations; Pertussis; ImmunoglobulinsLast Updated:May 12, 2023Not yet recruiting
Condition(s):Dermatitis AtopicLast Updated:March 15, 2024Recruiting
Condition(s):Rheumatic DiseasesLast Updated:February 14, 2024Active, not recruiting
Condition(s):Rotavirus Gastroenteritis; Diphtheria; Tetanus; PertussisLast Updated:October 9, 2015Withdrawn
Condition(s):PertussisLast Updated:March 16, 2022Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.